Market Movers (8-K)
See all →AUVIQ
Applied Uv, INCApplied UV, Inc. and its subsidiary SteriLumen, Inc. have filed for Chapter 11 bankruptcy, leading to the delisting of their stock from Nasdaq.
Worse than expected
AUVIQ
Applied Uv, INCApplied UV, Inc. has been notified by Nasdaq for failing to file its quarterly report on time, potentially leading to delisting if a compliance plan is not accepted.
Worse than expected
Delay expected
AUVIQ
Applied Uv, INCApplied UV, Inc. reports the resignations of two board members, Christopher Kochuba and Joseph Luhukay, effective May 21 and May 24, 2024, respectively.
AUVIQ
Applied Uv, INCApplied UV, Inc. has received a notice from Nasdaq stating that its common stock has failed to maintain the minimum $1.00 per share bid price, placing it at risk of delisting.
Worse than expected
AUVIQ
Applied Uv, INCApplied UV, Inc. has announced the resignation of Mazars USA LLP as their independent registered public accounting firm, effective May 14, 2024.
AUVIQ
Applied Uv, INCApplied UV received a notice from Nasdaq for not meeting the minimum independent director requirement on its audit committee following a director's resignation.
Worse than expected
Annual Reports (10-K)
AUVIQ
Applied Uv, INCApplied UV, Inc. reports a significant increase in revenue for 2023, driven by strategic acquisitions and growth in key market segments, while also addressing challenges related to profitability and internal controls.
Capital raise
Worse than expected
New Public Companies (S-1)
AUVIQ
Applied Uv, INCApplied UV, Inc. has filed an amendment to its Form S-1 registration statement to allow selling stockholders to offer and resell up to 518,065 shares of common stock issuable upon exercise of warrants.
Capital raise
AUVIQ
Applied Uv, INCApplied UV, Inc. has filed a registration statement for the potential resale of up to 518,065 shares of its common stock by selling stockholders, which are issuable upon the exercise of warrants issued in a private placement.